Drug
CXA-10 clinical trials
Also written CXA-10.
- studies test it
- 10
- open now
- 1
- in phase 3
- 0
- first study started
- 2014
Keep track of what changes. Save the CXA-10 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
9 studies that test it; most in 2015 (3)
| Year | Studies |
|---|---|
| 2014 | 2 |
| 2015 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 3
Complexa, Inc. (7) · University of Colorado, Denver (1) · Gladwin, Mark, MD (1) · Sally E. Wenzel MD (1)
Often tested with
Tested in the same studies.
Pravastatin (1) · Ezetimibe, Simvastatin Drug Combination (1)
Studies
Open first, then newest update. How each study uses CXA-10 is read from its arms, and is right about nine times in ten.
Testing it · 10
- Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in AsthmaRecruitingPhase 2University of Colorado, DenverNCT03762395Written as CXA-10
- Oral CXA-10 in Pulmonary Arterial HypertensionTerminatedPhase 2Gladwin, Mark, MDNCT04125745Written as CXA-10
- CXA-10 Study in Subjects With Pulmonary Arterial HypertensionTerminatedPhase 2Complexa, Inc.NCT04053543Written as CXA-10
- FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)CompletedPhase 2Complexa, Inc.NCT03422510Written as CXA-10
- Anti-Inflammatory Lipid Mediators in AsthmaWithdrawnPhase 2Sally E. Wenzel MDNCT03680976Written as CXA-10
- Study of CXA-10 in Healthy VolunteersCompletedPhase 1Complexa, Inc.NCT02127190Written as CXA-10 emulsion
- Open-Label Safety, Tolerability, PK Study of IV CXA-10 Emulsion in Subjects in Chronic Kidney InjuryCompletedPhase 1Complexa, Inc.NCT02248051Written as CXA-10
- PK and PD of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male SubjectsCompletedPhase 1Complexa, Inc.NCT02460146Written as CXA-10
- Oral CXA-10 Study in Healthy VolunteersCompletedPhase 1Complexa, Inc.NCT02313064Written as CXA-10
- A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy MalesCompletedPhase 1Complexa, Inc.NCT02547402Written as CXA-10
As the comparator · 1 — what is tested is compared with CXA-10
Codes
What other systems call CXA-10 · ClinicalTrials.gg INT001240
- MeSH (NLM) C000656258CXA-10Confirmed ClinicalTrials.gov, NLM
- UNII (FDA) 1N19AGY57YCXA-10One source NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000656258 | CXA-10 | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 1N19AGY57Y | CXA-10 | One source NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.